Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zurlo

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Anti-Cancer Drugs|November 21, 1998
Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I studyR Paridaens, J Thomas, J Wildiers, et al.
Anti-Cancer Drugs|May 4, 2001
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxelJ M Meerum Terwogt, W W ten Bokkel Huinink, J H Schellens, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Anti-Cancer Drugs|November 21, 1998
Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I studyR Paridaens, J Thomas, J Wildiers, et al.
Anti-Cancer Drugs|May 4, 2001
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxelJ M Meerum Terwogt, W W ten Bokkel Huinink, J H Schellens, et al.
Pageof 4